Concepedia

Mary Ellen Ruzycky

ME

Statistics

Publications

4

Citations

895

H-Index

4

Active since

2011

Affiliations

University of Pittsburgh(Current)

Helen Hayes Hospital

University of California, San Francisco

University of Sheffield

University of Auckland

Mary Ellen Ruzycky is an author at University of Pittsburgh specializing in metabolic bone disease, fracture prevention, and bone health.

Publications per year

2011–2018

4

Publications

4

The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

Dennis M. Black, Ian R. Reid, Steven Boonen et al. · Journal of Bone and Mineral Research · 2011 · 695 citations · Full text

, , +10

The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

Dennis M. Black, Ian R. Reid, Jane A. Cauley et al. · Bone · 2011 · 80 citations

, , +9

Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial

Timo Vesikari, Judith L. Kirstein, Grace Devota Go et al. · The Lancet Respiratory Medicine · 2018 · 67 citations

, , +16

The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

Dennis M. Black, Steven Boonen, Jane A. Cauley et al. · Journal of Bone and Mineral Research · 2012 · 53 citations · Full text

, , +10

1–4 of 4